Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Description of Severe Asthma Patients in a Cross-sectional Study-the IDEAL Study

NCT02293265 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02293265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Description of Severe Asthma Patients in a Cross-sectional Study-the IDEAL Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2014
Completion date
May 31, 2015
Enrollment
767 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

asthma